Riskified Ltd (RSKD)vsZepp Health Corp (ZEPP)
RSKD
Riskified Ltd
$4.75
+3.04%
TECHNOLOGY · Cap: $661.00M
ZEPP
Zepp Health Corp
$18.43
+5.50%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Riskified Ltd generates 33% more annual revenue ($344.64M vs $258.90M). RSKD leads profitability with a -8.0% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).
RSKD
Avoid34
out of 100
Grade: F
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.4%
Fair Value
$13.92
Current Price
$4.75
$9.17 discount
Margin of Safety
+48.8%
Fair Value
$46.82
Current Price
$18.43
$28.39 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Operating margin of 0.6%
ROE of -8.1% — below average capital efficiency
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : RSKD
The strongest argument for RSKD centers on Debt/Equity, Price/Book.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : RSKD
The primary concerns for RSKD are EPS Growth, Market Cap, Operating Margin.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
RSKD profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZEPP scores higher overall (41/100 vs 34/100) and 43.0% revenue growth. RSKD offers better value entry with a 68.4% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Riskified Ltd
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Riskified Ltd. is a premier provider of advanced fraud prevention solutions tailored specifically for eCommerce merchants, utilizing cutting-edge machine learning and data analytics to deliver real-time risk assessments. The company's proprietary platform not only enhances transaction approval rates but also significantly reduces fraud-related losses, thereby safeguarding merchants' revenue while ensuring a seamless customer experience. As a key player in the burgeoning digital payments sector, Riskified is strategically positioned for sustained growth and innovation, cementing its leadership role in the dynamic eCommerce landscape. The company’s ongoing commitment to technology advancement reinforces its value proposition and competitive edge in a rapidly evolving market.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?